Juno Capital Partners
Venture capitalLondon · Seed · 2 people tracked
Investment thesis
Juno Capital Partners concentrates on seed-stage investing, targeting early companies that already demonstrate some traction and have a defined growth strategy leading toward a Series A round.
Source: firm website, verified Aug 2, 2026.
Team · 2 people
from the firm's websiteFounding Partner at Juno Capital, responsible for dealflow, due diligence and portfolio management, and a board member at Sky Medical, Cloud.IQ, Cyclr and Synchtank. He previously was a partner at Longbow Capital and qualified as a Chartered Accountant with KPMG.
Co-founder of Juno Capital who previously worked at Cazenove and Longbow Capital, with extensive experience in EIS-qualifying investments and family office capital. He holds a PhD in venture from Swansea, an MBA from Henley and a Chemistry degree from Durham, and is an Honorary Research Fellow at Swansea's School of Management.
Frequently asked questions
- What stage does Juno Capital Partners invest at?
- Juno Capital Partners invests at the Seed stage.
- What sectors does Juno Capital Partners focus on?
- Juno Capital Partners focuses on Biotech, Cleantech, Consumer, Energy, Enterprise Software, Medical Devices, SaaS.
- Where is Juno Capital Partners located?
- Juno Capital Partners is headquartered in London, GB.
Similar investors
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Lerer Hippeau is a New York-based venture capital firm that leverages the city and its networks to support founders.
Mohr Davidow Ventures is a venture capital firm that invests across energy and materials, Internet services, life sciences, semiconductors, software, and systems sectors.
SBI Investment, a subsidiary of SBI Holdings established in 1996, invests in information technology, biotechnology, and life science companies across venture capital funds and provides advisory services including financial administration and public offering guidance. The firm operates as a venture capital investor based in Japan.